Jeri Sumitani

490 total citations
17 papers, 342 citations indexed

About

Jeri Sumitani is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Jeri Sumitani has authored 17 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in General Health Professions. Recurrent topics in Jeri Sumitani's work include HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (4 papers) and HIV/AIDS drug development and treatment (4 papers). Jeri Sumitani is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (4 papers) and HIV/AIDS drug development and treatment (4 papers). Jeri Sumitani collaborates with scholars based in United States, South Africa and Republic of the Congo. Jeri Sumitani's co-authors include Wendy S. Armstrong, Nancy L. Fleischer, Matthew Murphy, A. Rana Bayakly, Jonathan Colasanti, Hope M. Tiesman, Carlos del Rı́o, Yiran Zhang, C. Christina Mehta and Minh Ly Nguyen and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and American Journal of Preventive Medicine.

In The Last Decade

Jeri Sumitani

15 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeri Sumitani United States 7 205 102 98 91 67 17 342
Aparna Nishikant Shrotri India 12 176 0.9× 132 1.3× 139 1.4× 17 0.2× 45 0.7× 24 399
Susan Kaai Canada 11 221 1.1× 153 1.5× 153 1.6× 17 0.2× 127 1.9× 32 386
Julius Koech Kenya 12 123 0.6× 146 1.4× 63 0.6× 11 0.1× 5 0.1× 18 388
Eden V. Wells United States 12 114 0.6× 70 0.7× 111 1.1× 8 0.1× 26 0.4× 25 375
Yilkal Tafere Ethiopia 9 76 0.4× 40 0.4× 50 0.5× 10 0.1× 6 0.1× 24 240
Noelle A. Benzekri United States 8 154 0.8× 60 0.6× 87 0.9× 5 0.1× 10 0.1× 19 276
Toan Ha United States 10 190 0.9× 89 0.9× 169 1.7× 7 0.1× 10 0.1× 45 335
Malango Msukwa Malawi 9 336 1.6× 224 2.2× 166 1.7× 22 0.2× 5 0.1× 16 434
Celeste Philip United States 4 56 0.3× 90 0.9× 62 0.6× 25 0.3× 7 0.1× 9 267
Surajudeen Abiola Abdulrahman Malaysia 8 61 0.3× 83 0.8× 32 0.3× 4 0.0× 42 0.6× 26 268

Countries citing papers authored by Jeri Sumitani

Since Specialization
Citations

This map shows the geographic impact of Jeri Sumitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeri Sumitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeri Sumitani more than expected).

Fields of papers citing papers by Jeri Sumitani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeri Sumitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeri Sumitani. The network helps show where Jeri Sumitani may publish in the future.

Co-authorship network of co-authors of Jeri Sumitani

This figure shows the co-authorship network connecting the top 25 collaborators of Jeri Sumitani. A scholar is included among the top collaborators of Jeri Sumitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeri Sumitani. Jeri Sumitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Colasanti, Jonathan, Victoria Robinson, Erica Anderson, et al.. (2025). Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South. Clinical Infectious Diseases.
2.
Sales, Jessica M., et al.. (2024). Clinic-level complexities prevent effective engagement of people living with HIV who are out-of-care. PLoS ONE. 19(5). e0304493–e0304493. 1 indexed citations
3.
Murphy, Thomas J., Jeri Sumitani, Bradley L. Smith, et al.. (2024). Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South. AIDS Research and Human Retroviruses. 40(12). 690–700. 6 indexed citations
4.
Shade, Starley B., Emily Agnew, Jessica S. Grignon, et al.. (2024). Cost Analysis of Short Messaging Service and Peer Navigator Interventions for Linking and Retaining Adults Recently Diagnosed With HIV in Care in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 95(5). 417–423.
5.
Farber, Eugene W., Jeri Sumitani, Kirk A. Easley, et al.. (2023). The CARES Program: Improving Viral Suppression and Retention in Care Through a Comprehensive Team-Based Approach to Care for People with HIV and Complex Psychosocial Needs. AIDS Patient Care and STDs. 37(8). 416–424. 3 indexed citations
6.
Leslie, Hannah H., Alyssa Mooney, Hailey Gilmore, et al.. (2022). Prevalence, motivation, and outcomes of clinic transfer in a clinical cohort of people living with HIV in North West Province, South Africa. BMC Health Services Research. 22(1). 1584–1584. 4 indexed citations
7.
Lippman, Sheri A., Emily Agnew, Hailey Gilmore, et al.. (2022). Impact of short message service and peer navigation on linkage to care and antiretroviral therapy initiation in South Africa. AIDS. 37(4). 647–657. 6 indexed citations
8.
Collins, Lauren F., et al.. (2022). Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South. Open Forum Infectious Diseases. 9(9). ofac455–ofac455. 44 indexed citations
9.
Steward, Wayne T., Emily Agnew, Jeri Sumitani, et al.. (2021). Impact of SMS and peer navigation on retention in HIV care among adults in South Africa: results of a three‐arm cluster randomized controlled trial. Journal of the International AIDS Society. 24(8). e25774–e25774. 18 indexed citations
10.
Collins, Lauren F., et al.. (2021). 887. Implementation of Long-acting Injectable Cabotegravir/Rilpivirine for HIV-1 Treatment at a Ryan White-funded Clinic in the U.S. South. Open Forum Infectious Diseases. 8(Supplement_1). S535–S535. 3 indexed citations
11.
Colasanti, Jonathan, Jeri Sumitani, C. Christina Mehta, et al.. (2018). Implementation of a Rapid Entry Program Decreases Time to Viral Suppression Among Vulnerable Persons Living With HIV in the Southern United States. Open Forum Infectious Diseases. 5(6). ofy104–ofy104. 73 indexed citations
12.
Steward, Wayne T., Jeri Sumitani, Jessica Morris, et al.. (2017). Engaging HIV-positive clients in care: acceptability and mechanisms of action of a peer navigation program in South Africa. AIDS Care. 30(3). 330–337. 36 indexed citations
13.
14.
15.
Steward, Wayne T., Parya Saberi, John Tumbo, et al.. (2015). Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa. AIDS Care. 27(10). 1275–1278. 4 indexed citations
16.
17.
Fleischer, Nancy L., et al.. (2013). Public Health Impact of Heat-Related Illness Among Migrant Farmworkers. American Journal of Preventive Medicine. 44(3). 199–206. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aparna Nishikant Shrotri Breakdown of academic impact, for papers by Susan Kaai Breakdown of academic impact, for papers by Julius Koech Breakdown of academic impact, for papers by Eden V. Wells Breakdown of academic impact, for papers by Yilkal Tafere Breakdown of academic impact, for papers by Noelle A. Benzekri Breakdown of academic impact, for papers by Toan Ha Breakdown of academic impact, for papers by Malango Msukwa Breakdown of academic impact, for papers by Celeste Philip Breakdown of academic impact, for papers by Surajudeen Abiola Abdulrahman
Rankless by CCL
2026